(Q24246127)

2

0 references

Julia V Cook

3

0 references

Fiona Campbell

4

0 references

Fiona R Beyer

5

0 references

Gary A Ford

6

0 references

James Mason

Cochrane Database of Systematic Reviews

7

0 references

publication date

19 April 2006

0 references

published in

0 references

cites work

Calcium supplementation in patients with essential hypertension: assessment by office, home and ambulatory blood pressure.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Controlled trial of long-term oral calcium supplementation in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Epidemiologic association between dietary calcium intake and blood pressure: a meta-analysis of published data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Trials of Hypertension Prevention (TOHP) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Sodium intake, high blood pressure, and calcium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

A Randomized Controlled Trial of Stress Reduction for Hypertension in Older African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Dairy augmentation of total and central fat loss in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Science, medicine, and the future. Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

British guidelines on managing hypertension. Provide evidence, progress, and an occasional missed opportunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Calcium and blood pressure. An epidemiologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Dietary Approaches to Stop Hypertension: rationale, design, and methods. DASH Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Reduction of Blood Pressure With Calcium Supplementation in Young Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

Does Oral Calcium Supplementation Lower High Blood Pressure? A Double Blind Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Effect of calcium supplementation on diastolic blood pressure in young people with mild hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Effect of skim milk supplementation on blood cholesterol concentration, blood pressure, and triglycerides in a free-living human population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Potassium, calcium, alcohol intake and blood pressure: the Zutphen Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Oral calcium and blood pressure: a controlled intervention trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Metabolic differences between subjects whose blood pressure did or did not respond to oral calcium supplementation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Calcium intake and the relationship of dietary sodium and potassium to blood pressure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Calcium treatment of essential hypertension in elderly patients evaluated by 24 H monitoring

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Effect of calcium supplementation in an older population with mildly increased blood pressure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

The blood pressure effects of calcium supplementation in humans of known sodium responsiveness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Clinical observation of treatment of hypertension with calcium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

The inconsistent effects of calcium supplements upon blood pressure in primary hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Controlled trial of low calcium versus high calcium intake in mild hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Double-blind randomized, crossover trial of calcium supplementation in essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Oral calcium supplementation and blood pressure: an overview of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Dietary calcium intake and blood pressure in normotensive subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Hypertension and calcium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Dietary electrolytes and blood pressure: a statement for healthcare professionals from the American Heart Association Nutrition Committee

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Effect of calcium carbonate on blood pressure in normotensive and hypertensive people

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Long-term oral calcium supplementation reduces diastolic blood pressure in end stage renal disease. A randomized, double-blind, placebo controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021

Blood pressure response to oral calcium in persons with mild to moderate hypertension. A randomized, double-blind, placebo-controlled, crossover trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004639.PUB2

7 January 2021